These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 4377841)
1. Ultrastructural changes in psoriatic epidermis following anthralin treatment. Wilborn WH; Montes LF J Cutan Pathol; 1974; 1(3):132-50. PubMed ID: 4377841 [No Abstract] [Full Text] [Related]
2. [Dynamics of regression of psoriatic changes under the effect of cygnoline in the light of ultrastructural studies. II. Psoriatic changes after treatment with cygnoline]. Szczeklik-Franek A; Rubisz-Brzezińska JA; Grzybek H Patol Pol; 1979; 30(1):43-8. PubMed ID: 503597 [No Abstract] [Full Text] [Related]
3. Mast cell alterations in chronic psoriasis vulgaris: response to low-strength anthralin treatment. A transmission electron microscopic study. Brody I Ups J Med Sci; 1986; 91(1):1-16. PubMed ID: 3716018 [TBL] [Abstract][Full Text] [Related]
5. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy. Yamamoto T; Nishioka K Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829 [TBL] [Abstract][Full Text] [Related]
6. Low strength anthralin in psoriasis. Montes LF; Wilborn WH; Brody I J Cutan Pathol; 1979 Dec; 6(6):445-56. PubMed ID: 42654 [TBL] [Abstract][Full Text] [Related]
7. Treatment of psoriasis with the Ingram anthralin paste regimen. Ross JB; Guptill J Can Med Assoc J; 1982 Mar; 126(5):496. PubMed ID: 7066806 [No Abstract] [Full Text] [Related]
8. Detection of anthralin in skin during treatment. Juhlin L; Schroot B Acta Derm Venereol Suppl (Stockh); 1985; 120():27-9. PubMed ID: 3869415 [TBL] [Abstract][Full Text] [Related]
9. A 'novel' action of anthralin. Lotti T; Brunetti L; Panconesi E Arch Dermatol; 1986 Jul; 122(7):748-9. PubMed ID: 3729504 [No Abstract] [Full Text] [Related]
10. Treatment of psoriasis vulgaris: gentleness to the entire psoriatic skin and the use of low concentrations of anthralin. Brody I Br J Dermatol; 1981 Aug; 105 Suppl 20():109-10. PubMed ID: 7284255 [No Abstract] [Full Text] [Related]
11. Clinical signs of response to treatment in psoriasis--a cell kinetic and histological assessment using the IBAS II image analyser. Newton JA; Camplejohn RS; Bowyer C; Graham RM; McGibbon DM; Wright NA Clin Exp Dermatol; 1985 Jan; 10(1):36-40. PubMed ID: 3987084 [No Abstract] [Full Text] [Related]
12. [Disappearance of psoriactic lesions under the effect of anthralin]. Chowaniec O Przegl Dermatol; 1976; 63(5):665-71. PubMed ID: 1005760 [No Abstract] [Full Text] [Related]
14. Dithranol in a cream base in the treatment of psoriasis. Wargon O; Paver WK Australas J Dermatol; 1982 Dec; 23(3):123-5. PubMed ID: 7183304 [No Abstract] [Full Text] [Related]
15. Dithranol for psoriasis. Whitefield M Lancet; 1979 Mar; 1(8117):666. PubMed ID: 85893 [No Abstract] [Full Text] [Related]
16. A topical treatment program for psoriasis with low anthralin concentrations. Brody I; Johansson A J Cutan Pathol; 1977 Oct; 4(5):233-43. PubMed ID: 342554 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the short-duration dithranol and Dithrocream therapy in the treatment of psoriasis. Fräki JE; Neittaanmäki H; Väätäinen N Dermatologica; 1985; 171(1):52-4. PubMed ID: 4029462 [TBL] [Abstract][Full Text] [Related]
19. Treatment of psoriasis with dithranol cream in general practice. Ellis JP; Hindson TC; Hudson PM; Rhodes EL; Vollum DI; Walker AE Practitioner; 1984 Feb; 228(1388):219-26. PubMed ID: 6701151 [No Abstract] [Full Text] [Related]
20. [Effect of coal tar on cignolin erythema--1 hour treatment of psoriasis with high-dose cignolin with and without tar]. Schauder S; Mahrle G Z Hautkr; 1985 Jun; 60(11):875-83. PubMed ID: 3160177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]